The Failed Medical: PSV's Seven Million Euros Stranded in Adamo Nagalo

I once waited hours in the corridor of a hospital in Europe, waiting for a player to emerge from the examination room to find out whether he would make it back for the final match of the season. The corridor was cold, smelling of antiseptic, with the even tapping of medical staff footsteps on the tile. When the door opened, no one needed to say anything — you could tell from the face. For Adamo Nagalo, that door opened the worst possible way: a medical examination in Turkey, which was supposed to close a deal taking him away from PSV Eindhoven, collapsed right on the examination table. From that moment, the story was no longer about a player. It became a story about seven million euros stranded in the city of bicycles.

According to De Telegraaf and PSV watcher Jeroen Kapteijns, the Burkina Faso defender will not play again in the rest of the season. The club refuses to specify the problem, citing privacy rules — an increasingly common approach in Europe, where health data is classified as specially protected information. Nagalo arrived at PSV from FC Nordsjælland, the Danish club famous for developing and reselling talent, for a reported fee of around seven million euros. Two seasons later, his appearance count in the red-and-white shirt stopped at twelve.

Twelve appearances in two seasons. That is a number I usually pause over longer than a goal. In the beat-reporter trade, I learned that a player can be misjudged by goals, by assists, but appearances do not lie. Twelve across two campaigns and half a season on loan in Turkey with Konyaspor means Nagalo was never a pillar. He was a rotation option, an investment project, a name brought in to compete for the third or fourth centre-back slot — not to start every week. When you read a story like this, the important thing is not "PSV lost a centre-back." The important thing is "PSV lost an investment."

I have witnessed a small club wrestling with exactly this kind of asset. They bought a young player for a supposedly reasonable fee, betting on resale potential, then injuries came, then the deal fell through, then the book value just hung there like an unhealed wound. Modern football runs on numbers that never appear on the scoreboard. A player bought for seven million euros on a four-year contract sees his value decline each year on the club's books — accountants call it amortisation. If he plays and shines, the club sells him for more, clears the amortisation and books a profit. If he cannot play, the amortisation keeps running with nothing to offset it. That is when a player turns into a stranded loss.

For Nagalo, that stranded loss has a concrete name: roughly seven million euros paid to FC Nordsjælland, exchanged for twelve appearances and half a season on loan in Turkey. The on-pitch return on investment is near zero. And what makes the story more serious is how it ended: a sale to FK Çorum, said to be very close to completion in the summer, was blocked at the medical examination stage.

This is the truly expensive detail. A failed medical does not just cancel a transfer — it turns a private medical concern into a public red flag that the whole market can see. Before that examination, Nagalo's issue was an internal matter between PSV's medical staff and coaching team. After it, the information sits in the mind of every sporting director, every agent, every recruitment department in Europe. Any club that later sits at the negotiating table with PSV over Nagalo will know that this player once failed a medical at a Turkish club. The price will be discounted. The buyer pool will shrink.

I read this report and remembered what I once saw at smaller clubs. When I followed a club close to collapse, a foreign player suffered a serious injury just as borders closed and his family could not come. I took him to appointments, to wait for buses, and I wrote not a single line about it until he returned and scored. I learned one thing: some stories must ripen before you touch them. Nagalo's story is the opposite — it was exposed too early, and that exposure is itself part of the loss. From zero, I learned that the dressing-room door only opens when you dare to wait in the rain. But some doors open only to slam shut right in front of the person inside.

Look at the injury record. Before the current medical issue, Nagalo went through a long layoff with a shoulder injury. Add this failed medical, and the picture becomes clearer: this is not an isolated incident, but a pattern of availability. In the industry there is an unkind term for this type of player. Clubs increasingly attach tighter contract conditions, buy insurance, or simply price injury-prone players far lower. This protects the buyer but pushes risk onto the seller. PSV is now on the seller's side.

What stands out is that PSV still leaves open the possibility that Nagalo could yet leave. I read that line and could not help asking: is it information, or is it a signal? In my trade, I learned to tell these apart. A club trying to sell an asset the market has flagged red will always want to keep the exit path ajar. That is understandable, and also something to read with caution. Because the most plausible path for a player like Nagalo now is not a clean sale at a good price, but another loan, or an exit for a nominal fee. That is how clubs handle stranded assets: not to recover capital, but to ease the wage burden.

There is another dimension I always notice in stories like this. It is the flow of the market. Nagalo went from Denmark to the Netherlands, from a youth-development club to a big Eredivisie side. Then he was pushed to Turkey on loan, and then nearly sold to another Turkish club. That is a downward flow. When a big club cannot find buyers in Europe's top leagues, it must turn to more secondary markets. Football runs as a tiered system, and a player moving from one tier down to another is simultaneously a tactical and an economic signal: he did not meet the standard at the top tier, and his value must be repriced at a lower one.

Here, I see no sign that PSV faces systemic risk. This is a single stranded asset, not a financial crisis for the whole club. If anything is troubling, it is a question of process: how could a player bought for seven million euros, having passed an inbound medical, end up making only twelve appearances in two years and then resist sale for medical reasons? Three departments — scouting, medical, finance — should have coordinated at this point. At a small club I once accompanied, such a mistake could sink an entire season. At PSV, it is only a scratch. But repeated scratches become scars.

I write about the ball, but I keep the rhythm with the hearts of the people who play it. And the heart of a player at this age, when a career sits on the border between potential and stagnation, bears pressure very different from that of an established name. Nagalo is still young. He can still play in a smaller league, where he plays weekly, and rebuild his career. But for that to happen, someone must be willing to take on the medical risk. And in today's transfer market, where medicals grow ever stricter, the price of that willingness grows steeper.

For a young player, being named in a transfer story that collapsed on a medical is a hard-to-fade stain. It is not his fault. But the market does not run on fault or fairness. It runs on risk. Three hundred days without applause, I hear the players' breathing on the empty stands more clearly. At my own club, I once sat in a silent stadium and heard every stud pressing into wet grass. Moments like that taught me that behind every transfer story is a person waiting in silence.

The question I leave behind is not whether PSV lost too much money. The question is whether the market will remember the face of a player who failed a clinic, or only the red flag that clinic left behind. Football truly opens its doors only when someone dares to wait in the rain. And sometimes the rain does not just wash away a transfer. It washes away a person's second chance too — unless someone is patient enough to open the door for him again.